Journal Article10.1111/J.1464-5491.2011.03279.X
Lower extremity amputations — a review of global variability in incidence
Paul Moxey,P. Gogalniceanu,Robert J. Hinchliffe,Ian M. Loftus,K. J. Jones,Matt M. Thompson,Peter J. Holt +6 more
574
TL;DR: In this article, a literature review was performed using the EMBASE and MEDLINE databases from 1989 until 2010 for incidence of lower extremity amputation, showing significant variation with no single standard upon which to benchmark care.
read more
Abstract: Diabet. Med. 28, 1144–1153 (2011)
Abstract
Aim To quantify global variation in the incidence of lower extremity amputations in light of the rising prevalence of diabetes mellitus.
Methods An electronic search was performed using the EMBASE and MEDLINE databases from 1989 until 2010 for incidence of lower extremity amputation. The literature review conformed to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement standards.
Results Incidence of all forms of lower extremity amputation ranges from 46.1 to 9600 per 105 in the population with diabetes compared with 5.8–31 per 105 in the total population. Major amputation ranges from 5.6 to 600 per 105 in the population with diabetes and from 3.6 to 68.4 per 105 in the total population. Significant reductions in incidence of lower extremity amputation have been shown in specific at-risk populations after the introduction of specialist diabetic foot clinics.
Conclusion Significant global variation exists in the incidence of lower extremity amputation. Ethnicity and social deprivation play a significant role but it is the role of diabetes and its complications that is most profound. Lower extremity amputation reporting methods demonstrate significant variation with no single standard upon which to benchmark care. Effective standardized reporting methods of major, minor and at-risk populations are needed in order to quantify and monitor the growing multidisciplinary team effect on lower extremity amputation rates globally.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
•Journal Article
A concordance study between hospital discharge data and medical records for the recording of lower extremity amputation and diabetes in the Republic of Ireland
Claire M. Buckley,Patricia M. Kearney,C. Ni Bhuachalla,Caoimhe Casey,Fauzi Ali,Graham A Roberts,Ivan J. Perry,Colin P Bradley +7 more
10
Effects of social deprivation and healthcare access on major amputation following a diabetic foot ulcer in a French administrative area: Analysis using the French claim data
Jean-Baptiste Bonnet,Guillaume Nicolet,Laurence Papinaud,Antoine Avignon,Claire Duflos,Ariane Sultan +5 more
TL;DR: The study objective was to evaluate the relationship between lower limb amputation, social deprivation level, and inequalities in access to care service among people with DFU.
Diabetes-related lower extremity complications in a multi-ethnic Asian population: a 10 year observational study in Singapore.
Tessa Riandini,Deanette Pang,Matthias Paul Han Sim Toh,Chuen Seng Tan,Daveon Yu Kai Liu,Andrew M.T.L. Choong,Sadhana Chandrasekar,E. Shyong Tai,Kelvin Bryan Tan,Kelvin Bryan Tan,Kavita Venkataraman +10 more
TL;DR: In this paper, the authors examined the epidemiology of diabetes-related lower extremity complications (DRLECs): symptomatic peripheral arterial disease, ulceration, infection, gangrene) and amputations in a multi-ethnic Asian population.
Efficacy of LL-37 cream in enhancing healing of diabetic foot ulcer: a randomized double-blind controlled trial
Eliza Miranda,Kusmarinah Bramono,Em Yunir,Mirta Hediyati Reksodiputro,Oki Suwarsa,Iris Rengganis,Alida Harahap,Decy Subekti,Suhendro Suwarto,Hayun Hayun,Saptawati Bardosono,J. C. Baskoro +11 more
TL;DR: LL-37 cream enhanced the healing rate of DFU with mild infection, but did not decrease the levels of IL-1α and TNF-α and the number of aerobic bacteria colonization.
10
References
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher,Alessandro Liberati,Alessandro Liberati,Jennifer Tetzlaff,Douglas G. Altman test +4 more
TL;DR: PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is introduced, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses.
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
TL;DR: Since most patients with diabetes die from complications of atherosclerosis, they should receive intensive preventive interventions proven to reduce their cardiovascular risk.
2.9K
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.
Anne B. Newman,David S. Siscovick,Teri A. Manolio,Joseph F. Polak,Linda P. Fried,Nemat O. Borhani,Sidney K. Wolfson +6 more
TL;DR: There was an inverse dose-response relation of the AAI with CVD risk factors and subclinical and clinical CVD among older adults, and even those with modest, asymptomatic reductions in theAAI appear to be at increased risk of CVD.
1.2K